Application of a Poisson distribution quality control measure to the analysis of two human hookworm drug treatment studies in Ghana.
Application of a Poisson distribution quality control measure to the analysis of two human hookworm drug treatment studies in Ghana.
复制标题
应用泊松分布质量控制措施分析加纳的两项人类钩虫药物治疗研究。
DOI:
10.1016/j.ijpddr.2014.01.001
复制
发表时间:
2014
期刊:
影响因子:
--
通讯作者:
Cappello,Michael
中科院分区:
文献类型:
--
作者:
Kotze,AndrewC;Dobson,RobertJ;Humphries,Debbie;Wilson,Michael;Cappello,Michael
We examined faecal egg count reduction tests (FECRTs) conducted with hookworm-infected humans in Ghana in 2007 (study 1) and 2010 (study 2) in order to explore aspects of the test analysis. Some subjects showed increased FEC following drug treatment. This occurred mostly in <150 epg pre-treatment FEC subjects. We sought a means to remove ‘erroneous’ negative drug efficacy cases from the FECRT analysis. Pre- and post-treatment FECs from negative drug efficacy cases were examined to determine whether they represented replicates from a single randomly distributed sample, that is, if they were consistent with a Poisson distribution. Cases where the post-treatment FEC was greater than that expected if it and the pre-treatment sample had been taken from a single random distribution of eggs were excluded from the FECRT. We suggest that these cases most likely represent non-random distribution of eggs in stools, day-to-day variations in egg excretion, or worm patency onset after drug treatment, and hence are not accurate measurements of drug efficacy. This led to exclusion of the most extreme negative drug efficacy cases, with significant increases in overall drug efficacy for study 1 (81.6% vs 89.2%) and study 2 (86.7% vs 89.4%). Excluding FEC <150 individuals from the analysis also increased the study 1 efficacy (81.6% vs 88.9%), however, this resulted in the exclusion of 45% of the study subjects, compared to the exclusion of just 5% using the Poisson distribution method. While low FEC subjects are excluded from livestock FECRTs, the significant prevalence of such subjects in human FECRTs suggests that their exclusion may not be practical. Hence, we suggest that the influence of low FECs can be minimised by excluding ‘erroneous’ negative efficacy cases using a simple Poisson distribution analysis.
登录
查看更多内容
影响因子:
2.6
作者:
P. Torgerson;M. Paul;F. Lewis
通讯作者:
F. Lewis
影响因子:
1.5
作者:
Albonico, M;Wright, V;Bickle, Q
通讯作者:
Bickle, Q
DOI:
10.4269/ajtmh.2011.11-0003
发表时间:
2011-05-01
影响因子:
3.3
作者:
Humphries, Debbie;Mosites, Emily;Cappello, Michael
通讯作者:
Cappello, Michael
影响因子:
4
作者:
Albonico, M;Wright, V;Bickle, Q
通讯作者:
Bickle, Q
影响因子:
1.3
作者:
BEAVER, PC
通讯作者:
BEAVER, PC